Trial intelligence / Profile preview

PRENOXA: Enox vs Lovenox for DVT Prophylaxis in Orthopedic Surgery

NCT01354704Phase 4Completed

Sponsor
Les Laboratoires des Médicaments Stériles
Start
Mar 2011
Primary completion
Jul 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of enoxaparin in deep vein thrombosis (DVT), sponsored by Les Laboratoires des Médicaments Stériles. Started Mar 2011; status: completed.

02

Drugs

enoxaparin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT01354704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01354704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call